Unaltered SNARE complex formation in an in vivo model of prion disease

Brain Research

Volumn 1233, Issue , 2008, Pages 1-7

  Asuni, Ayodeji A ^a   Cunningham, Colm ^a   Vigneswaran, Piranavhan ^a   Perry, V Hugh ^a   O'Connor, Vincent ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Hippocampus; Neurodegeneration; Neurotransmitter release; Prion; SNARE complex; Synaptopathy; Syntaxin

Indexed keywords

SNARE PROTEIN; TRITON X 100;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; EXTRACTION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRION DISEASE; PRIORITY JOURNAL; SYNAPTIC EFFICACY;

ANIMALS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HIPPOCAMPUS; LONGITUDINAL STUDIES; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; OCTOXYNOL; PRION DISEASES; PROTEIN FOLDING; PRPSC PROTEINS; QA-SNARE PROTEINS; R-SNARE PROTEINS; SNARE PROTEINS; SYNAPTIC TRANSMISSION; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TISSUE EXTRACTS;

EID: 51449094585     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.07.083     Document Type: Article

References (32)

1. Asuni A.A., Hooper C., Reynolds C.H., Lovestone S., Anderton B.H., and Killick R. GSK3alpha exhibits beta-catenin and tau directed kinase activities that are modulated by Wnt. Eur. J. Neurosci. 24 (2006) 3387-3392
2. Bennett M.K., Calakos N., and Scheller R.H. Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science 257 (1992) 255-259
3. Betmouni S., and Perry V.H. The acute inflammatory response in CNS following injection of prion brain homogenate or normal brain homogenate. Neuropathol. Appl. Neurobiol. 25 (1999) 20-28
4. Blasi J., Binz T., Yamasaki S., Link E., Niemann H., and Jahn R. Inhibition of neurotransmitter release by clostridial neurotoxins correlates with specific proteolysis of synaptosomal proteins. J. Physiol. Paris 88 (1994) 235-241
5. Borchelt D.R., Scott M., Taraboulos A., Stahl N., and Prusiner S.B. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J. Cell. Biol. 110 (1990) 743-752
6. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75 (2006) 333-366
7. Chiti Z., Knutsen O.M., Betmouni S., and Greene J.R. An integrated, temporal study of the behavioural, electrophysiological and neuropathological consequences of murine prion disease. Neurobiol. Dis. 22 (2006) 363-373
8. Cummings C.J., Orr H.T., and Zoghbi H.Y. Progress in pathogenesis studies of spinocerebellar ataxia type 1. Philos. Trans. R Soc. Lond. B. Biol. Sci. 354 (1999) 1079-1081
9. Cunningham C., Deacon R., Wells H., Boche D., Waters S., Diniz C.P., Scott H., Rawlins J.N., and Perry V.H. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur. J. Neurosci. 17 (2003) 2147-2155
10. Fernandez-Chacon R., Wolfel M., Nishimune H., Tabares L., Schmitz F., Castellano-Munoz M., Rosenmund C., Montesinos M.L., Sanes J.R., Schneggenburger R., and Sudhof T.C. The synaptic vesicle protein CSP alpha prevents presynaptic degeneration. Neuron 42 (2004) 237-251
11. Ferrer I., Puig B., Blanco R., and Marti E. Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease. Neuroscience 97 (2000) 715-726
12. Fuhrmann M., Mitteregger G., Kretzschmar H., and Herms J. Dendritic pathology in prion disease starts at the synaptic spine. J. Neurosci. 27 (2007) 6224-6233
13. Galli T., McPherson P.S., and De Camilli P. The V0 sector of the V-ATPase, synaptobrevin, and synaptophysin are associated on synaptic vesicles in a Triton X-100-resistant, freeze-thawing sensitive, complex. J. Biol. Chem. 271 (1996) 2193-2198
14. Gray F., Chretien F., Adle-Biassette H., Dorandeu A., Ereau T., Delisle M.B., Kopp N., Ironside J.W., and Vital C. Neuronal apoptosis in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. 58 (1999) 321-328
15. Hanson P.I., Heuser J.E., and Jahn R. Neurotransmitter release - four years of SNARE complexes. Curr. Opin. Neurobiol. 7 (1997) 310-315
16. Hayashi T., McMahon H., Yamasaki S., Binz T., Hata Y., Sudhof T.C., and Niemann H. Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly. Embo J. 13 (1994) 5051-5061
17. Herms J., Tings T., Gall S., Madlung A., Giese A., Siebert H., Schurmann P., Windl O., Brose N., and Kretzschmar H. Evidence of presynaptic location and function of the prion protein. J. Neurosci. 19 (1999) 8866-8875
18. Jahn R., and Niemann H. Molecular mechanisms of clostridial neurotoxins. Ann. N. Y. Acad. Sci. 733 (1994) 245-255
19. Jeffrey M., Halliday W.G., Bell J., Johnston A.R., MacLeod N.K., Ingham C., Sayers A.R., Brown D.A., and Fraser J.R. Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol. Appl. Neurobiol. 26 (2000) 41-54
20. Kim Y.S., Carp R.I., Callahan S.M., Natelli M., and Wisniewski H.M. Vacuolization, incubation period and survival time analyses in three mouse genotypes injected stereotactically in three brain regions with the 22L scrapie strain. J. Neuropathol. Exp. Neurol. 49 (1990) 106-113
21. Mallucci G.R., White M.D., Farmer M., Dickinson A., Khatun H., Powell A.D., Brandner S., Jefferys J.G., and Collinge J. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 53 (2007) 325-335
22. Morris R.J., Parkyn C.J., and Jen A. Traffic of prion protein between different compartments on the neuronal surface, and the propagation of prion disease. FEBS Lett. 580 (2006) 5565-5571
23. Otto H., Hanson P.I., and Jahn R. Assembly and disassembly of a ternary complex of synaptobrevin, syntaxin, and SNAP-25 in the membrane of synaptic vesicles. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6197-6201
24. Pellegrini L.L., O'Connor V., Lottspeich F., and Betz H. Clostridial neurotoxins compromise the stability of a low energy SNARE complex mediating NSF activation of synaptic vesicle fusion. Embo J. 14 (1995) 4705-4713
25. Prusiner S.B. Molecular biology and genetics of prion diseases. Cold Spring Harb. Symp. Quant. Biol. 61 (1996) 473-493
26. Rowan M.J., Klyubin I., Wang Q., and Anwyl R. Mechanisms of the inhibitory effects of amyloid beta-protein on synaptic plasticity. Exp. Gerontol. 39 (2004) 1661-1667
27. Russelakis-Carneiro M., Hetz C., Maundrell K., and Soto C. Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts. Am. J. Pathol. 165 (2004) 1839-1848
28. Sandberg M.K., and Low P. Altered interaction and expression of proteins involved in neurosecretion in scrapie-infected GT1-1 cells. J. Biol. Chem. 280 (2005) 1264-1271
29. Scott J.R., Jeffrey M., and Halliday W.G. Unsuspected early neuronal loss in scrapie-infected mice revealed by morphometric analysis. Ann. N. Y. Acad. Sci. 724 (1994) 338-343
30. Siso S., Puig B., Varea R., Vidal E., Acin C., Prinz M., Montrasio F., Badiola J., Aguzzi A., Pumarola M., and Ferrer I. Abnormal synaptic protein expression and cell death in murine scrapie. Acta Neuropathol. (Berl) 103 (2002) 615-626
31. Yoshida A., Oho C., Omori A., Kuwahara R., Ito T., and Takahashi M. HPC-1 is associated with synaptotagmin and omega-conotoxin receptor. J. Biol. Chem. 267 (1992) 24925-24928
32. Zhang W., Wang T., Pei Z., Miller D.S., Wu X., Block M.L., Wilson B., Zhang W., Zhou Y., Hong J.S., and Zhang J. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. Faseb J. 19 (2005) 533-542